Luis Miguel Gonzalez-Perez | Medicine | Best Researcher Award

Prof. Dr. Luis Miguel Gonzalez-Perez | Medicine | Best Researcher Award

Virgen del Rocío University Hospital | Spain

Luis Miguel González Pérez is a distinguished specialist in Oral and Maxillofacial Surgery with an extensive career dedicated to clinical practice, academic instruction, and research advancement. Serving as a Faculty Specialist at the Hospital Universitario Virgen del Rocío since 2000, he has contributed significantly to complex surgical care within the Andalusian Health Service. His expertise encompasses mandibular reconstruction, temporomandibular joint (TMJ) tumors, myofascial pain syndromes, and innovative approaches in oral mucosal repair. Since 2016, he has served as a Professor in the Master’s Program in Pain Treatment at the University of Sevilla, where he also holds a long-standing appointment as an Associate Professor in the Department of Surgery. His academic roles emphasize curriculum development, clinical training, and interdisciplinary teaching focused on maxillofacial pathology and surgical management. His excellence in teaching and clinical practice has been recognized through professional accreditations, including the Clinical Contracted Doctor Accreditation (2015) and an Excellent Level Professional Competency Accreditation by the Andalusian Agency for Healthcare Quality (2012). González Pérez has led and contributed to several ongoing research projects, particularly in biomedical innovation. His notable research initiatives include the application of biomaterials for mandibular reconstruction, long-term studies on TMJ tumors, clinical investigations into myofascial pain syndrome, and advancements in oral mucosal reconstruction using cryopreserved human amniotic membrane grafts. His work integrates clinical experience with translational research, contributing to improved therapeutic strategies in maxillofacial surgery. Through his combined roles as clinician, educator, and researcher, he continues to influence the progress of surgical sciences and enrich the training of future healthcare professionals.

Profiles: Scopus | Orcid

Featured Publications

Gonzalez-Perez, L.-M., Montes-Carmona, J.-F., Torres-Carranza, E., & Infante-Cossio, P. (2023). Total joint replacement for immediate reconstruction following ablative surgery for primary tumors of the temporo-mandibular joint. Journal of Personalized Medicine, 13(7), 1021.

Gonzalez-Perez, L.-M., Vera-Martin, R., Montes-Latorre, E., Torres-Carranza, E., & Infante-Cossio, P. (2023). Botulinum toxin and percutaneous needle electrolysis for the treatment of chronic masticatory myalgia. Toxins, 15(4), 278.

Cabrera-Arcas, A., Montes-Carmona, J.-F., & Gonzalez-Perez, L.-M. (2022). Mandibular radiolucencies: A differential diagnosis of a rare tumor. Diagnostics, 12(7), 1651.

Montes-Carmona, J.-F., Gonzalez-Perez, L.-M., & Infante-Cossio, P. (2020). Treatment of localized and referred masticatory myofascial pain with botulinum toxin injection. Toxins, 13(1), 6.

Gonzalez-Perez, L. M. (2020). Application of human amniotic membrane in temporomandibular joint osteoarthritis. Journal of Craniofacial Surgery, 31(4), e–? (PMID: 32195845).

Dorota Wasko-Czopnik | Medicine | Academic Excellence Award

Assoc. Prof. Dr. Dorota Wasko-Czopnik | Medicine | Academic Excellence Award

Assoc. Prof. Dr. Dorota Wasko-Czopnik | Medicine | Wrocław University of Science and Technology | Poland

Prof. Dorota Waśko-Czopnik, MD, PhD, is a distinguished physician, academic, and researcher specializing in internal medicine, gastroenterology, and nutrition. With over 26 years of service at the Clinic of Gastroenterology, Hepatology, and Internal Medicine at Wrocław Medical University, she has made remarkable contributions to clinical practice and medical education. She previously served as head of the Gastrointestinal Motility Laboratory, where she advanced diagnostic and therapeutic approaches for functional gastrointestinal disorders. Currently, she is affiliated with the Department of Gastroenterology and Hepatology and the Inflammatory Bowel Disease Treatment Unit at the Provincial Specialist Hospital in Wrocław, while also teaching at the Faculty of Medicine, Wrocław University of Science and Technology. Author of more than 180 publications, monographs, and books, Prof. Waśko-Czopnik bridges medicine with dietetics and nutrition, offering an integrative perspective on patient care. A respected mentor, she supervises theses and doctoral dissertations, inspiring the next generation of medical professionals.

Author Profile

Orcid

Education

Prof. Dorota Waśko-Czopnik’s educational path reflects excellence in both medicine and nutrition. She graduated with a medical degree (MD) and further advanced her expertise by obtaining a PhD, focusing her research on gastroenterology and internal medicine. Her rigorous medical training culminated in earning a second-degree specialization in internal medicine, solidifying her clinical and academic foundation. She further enhanced her expertise by becoming a certified nutritional consultant, aligning her medical knowledge with a holistic understanding of dietetics and nutrition in patient care. Throughout her academic journey, she consistently demonstrated leadership in medical research and teaching, contributing extensively to the development of medical education. She has actively participated in postgraduate training programs, professional courses, and continuous medical education, ensuring she remains at the forefront of advancements in gastroenterology and hepatology. Her multidisciplinary educational background uniquely positions her to integrate internal medicine, gastroenterology, and nutritional sciences for innovative medical practices.

Experience

Prof. Dorota Waśko-Czopnik’s professional career spans nearly three decades of dedicated service in clinical medicine, research, and academia. For 26 years, she worked at the Clinic of Gastroenterology, Hepatology, and Internal Medicine at Wrocław Medical University, where she served as head of the Gastrointestinal Motility Laboratory and an esteemed lecturer. In her role, she combined clinical responsibilities with mentoring students and young researchers, shaping the academic and professional growth of numerous medical practitioners. Currently, she contributes her expertise at the Department of Gastroenterology and Hepatology and the Inflammatory Bowel Disease Treatment Unit of the Provincial Specialist Hospital in Wrocław, while also holding an academic position at the Faculty of Medicine of the Wrocław University of Science and Technology. Her experience includes supervising bachelor’s, master’s, and doctoral theses and evaluating advanced academic dissertations. A sought-after speaker, she has presented at national and international conferences, podcasts, and webinars.

Awards and Honors

Throughout her distinguished career, Prof. Dorota Waśko-Czopnik has received recognition for her contributions to medicine, research, and education. Her extensive publication record of over 180 scientific works, monographs, and books highlights her as a leading voice in gastroenterology, hepatology, and nutrition. She has been invited as a keynote lecturer at prestigious medical and dietetic conferences, underscoring her impact on both clinical and academic communities. Her leadership as head of the Gastrointestinal Motility Laboratory earned her respect within the medical community for advancing diagnostic practices. Prof. Waśko-Czopnik’s role as a mentor and thesis supervisor has also been honored, reflecting her commitment to developing future leaders in medicine. She has been recognized by national and European professional societies, including memberships in the Polish Society of Gastroenterology and the European Crohn’s and Colitis Organization. Her accolades represent not only personal achievements but also her significant contributions to advancing healthcare standards.

Research Focus

Prof. Dorota Waśko-Czopnik’s research is rooted in the intersection of gastroenterology, internal medicine, and nutrition, with a strong emphasis on functional gastrointestinal disorders. She has conducted pioneering work in gastrointestinal motility, contributing to the diagnosis and treatment of complex digestive diseases. Her studies extend into hepatology and inflammatory bowel diseases, where she integrates clinical practice with evidence-based dietary interventions. A certified nutritional consultant, she explores the relationship between dietetics and gastrointestinal health, offering patients innovative treatment strategies that combine medical therapy with lifestyle and nutritional modifications. She is also deeply engaged in the study of neurogastroenterology and microscopic colitis, contributing to both national and international collaborations. Her holistic approach to research highlights the importance of integrating nutrition science into gastroenterology to improve patient outcomes. Her ongoing projects and publications continue to bridge gaps between medicine, research, and patient education, positioning her as a leader in modern gastroenterology.

Publication Titles

  1. Gastrointestinal Motility: Clinical Insights and Applications

  2. Advances in Functional Gastrointestinal Disorder Management

  3. Nutrition and Gastroenterology: Bridging Medicine with Dietetics

  4. Hepatology Perspectives in Internal Medicine Practice

  5. Clinical Approaches to Inflammatory Bowel Disease Treatment

  6. Dietetics in Digestive Health and Patient Care

  7. Comprehensive Guide to Gastroenterology for Practitioners

  8. International Trends in Gastroenterological Research

  9. Academic Contributions in Gastrointestinal Disease Studies

  10. Medical Podcasts and Webinars on Nutrition and Health

Conclusion

Prof. Dorota Waśko-Czopnik stands as a highly accomplished physician, academic, and researcher whose career seamlessly integrates internal medicine, gastroenterology, and nutrition. Her impactful publications, leadership in medical education, and clinical expertise position her as an influential figure advancing modern healthcare. By combining scientific rigor with holistic patient-centered care, she continues to inspire both peers and future medical professionals, leaving a lasting legacy in the field of medicine.

Thomas Lehrnbecher | Medicine | Best Researcher Award

Prof. Dr. Thomas Lehrnbecher | Medicine | Best Researcher Award

Prof. Dr. Thomas Lehrnbecher | Medicine | Goethe Universität Frankfurt | Germany

Dr. Thomas Lehrnbecher is a distinguished pediatric oncologist and hematologist, serving as Head of the Division of Pediatric Hematology and Oncology at Johann Wolfgang Goethe University, Frankfurt. With decades of experience, his clinical and research expertise lies in infections in immunocompromised pediatric patients, supportive care, and innovative therapeutic strategies for childhood cancers. His career spans leading roles in Germany and international collaborations at the National Cancer Institute, USA, where he trained as a post-doctoral fellow. A prolific researcher, he has published extensively in high-impact journals, shaping global practices in infection management and antifungal prophylaxis in children with cancer. Dr. Lehrnbecher has also contributed significantly to medical societies, committees, and working groups, reflecting his leadership in advancing pediatric oncology. Recognized with prestigious awards, he continues to drive progress in medicine through innovative research, clinical care, and mentorship, making him an influential figure in pediatric hematology and oncology worldwide.

Author profile 

Orcid

Education

Dr. Lehrnbecher’s medical training reflects a strong foundation in pediatrics and subspecialization in oncology and infectious diseases. He earned his Board Exam in General Pediatrics in 1996, establishing his clinical foundation. His academic excellence and leadership were recognized in 2005, when he was awarded a Professorship at Johann Wolfgang Goethe University, Frankfurt, one of Germany’s leading medical institutions. That same year, he also earned a Diploma in Pediatric Infectious Diseases from the German Society for Pediatric Infectious Diseases, strengthening his expertise in managing complex infections. In 2007, he completed his Board Exam in Pediatric Hematology and Oncology, formally certifying his specialization in childhood cancers and blood disorders. Combined with his post-doctoral fellowship at the National Cancer Institute (NIH, USA), his education and training provided him with exceptional clinical and research competencies, which now serve as the foundation of his international reputation in pediatric oncology and infection medicine.

Experience

Dr. Lehrnbecher has cultivated an impressive career spanning over two decades in pediatric hematology and oncology. Since 2001, he has served as a Senior Consultant at Johann Wolfgang Goethe University, Frankfurt, providing expertise in pediatric cancer care and mentoring young clinicians. In 2018, he advanced to Head of the Division of Pediatric Hematology and Oncology, where he oversees patient care, clinical programs, and research initiatives. Earlier in his career, he worked as a Consultant at the Children’s Hospital, University of Würzburg (1999–2000), where he gained valuable clinical insights. A pivotal moment came during his post-doctoral fellowship at the National Cancer Institute, NIH, USA (1996–1999), under Dr. Stephen Chanock, where he developed a strong research focus on infections in immunocompromised children. His leadership in both clinical and research settings reflects his dedication to integrating science with practice, driving advancements in pediatric oncology, supportive care, and infection management worldwide.

Awards and Honors

Dr. Lehrnbecher’s contributions to pediatric oncology and infectious diseases have earned him numerous prestigious awards. In 2024, he received the Best Publication Award from the German Society of Mycology (DMykG), recognizing his impactful research. He previously won the Kind Philipp Award from the German Society of Pediatric Oncology and Hematology (GPOH) and the Poster Award from the International Society of Pediatric Oncology (SIOP). His groundbreaking work in mycology earned him the Outstanding Research in Mycology Award, while his contributions to histiocytic disorders were honored with the Nesbit Award from the Histiocyte Society. Earlier in his career, he was recognized with the Outstanding Research Award in Novel Therapeutic Strategies by the Children’s Cancer Foundation Mainz and the Educational Grant from the German Foundation of Cancer Aid. Collectively, these awards highlight his sustained excellence in clinical care, medical research, and innovation.

Research Focus

Dr. Lehrnbecher’s research is centered on improving the management of infections in immunocompromised pediatric patients, particularly those undergoing cancer treatment or hematopoietic stem cell transplantation. He has extensively studied antifungal prophylaxis, bacterial infections, and novel diagnostic markers for invasive fungal disease in children. His investigations aim to refine supportive care strategies, reduce infection-related mortality, and improve the quality of life for pediatric cancer patients. A particular focus of his research has been the efficacy of antifungal and antibiotic therapies, as well as the development of evidence-based guidelines for infection management. Beyond infectious diseases, his work also contributes to optimizing cancer treatment protocols, including long-term maintenance therapies for pediatric sarcomas. Through clinical trials, prospective studies, and international collaborations, Dr. Lehrnbecher has made significant advances in pediatric oncology. His contributions are widely recognized for bridging research and practice, helping set global standards for supportive care in children with cancer.

Publications

  • Assessing the Theoretical Efficacy of Combination Therapy Against Gram-Negative Infections in Neutropenic Pediatric Cancer Patients.

  • Mold-Active Antifungal Prophylaxis in Pediatric Patients with Cancer or Undergoing Hematopoietic Cell Transplantation.

  • Pediatric Patients with Stage IV Rhabdomyosarcoma Benefit from Long-Term Maintenance Therapy: CWS Trials Results.

  • Serum Beta-D-Glucan in the Diagnosis of Invasive Fungal Disease in Children: A Critical Analysis.

  • Cerebrospinal Fluid System Infection in Children with Cancer: A 14-Year Retrospective Analysis.

  • Infections during Non-Neutropenic Episodes in Pediatric Cancer Patients: A Prospective European Study.

Conclusion

Dr. Thomas Lehrnbecher is an internationally recognized leader in pediatric oncology and infectious diseases. His pioneering research, clinical leadership, and commitment to advancing supportive care in childhood cancer treatment have transformed patient outcomes worldwide. His achievements and continued impact make him a highly deserving candidate for the Medicine Award, symbolizing excellence in medical research and clinical innovation.

Inamul Hasan Madar | Medicine | Outstanding Scientist Award

Prof. Dr. Inamul Hasan Madar | Medicine | Outstanding Scientist Award

Prof. Dr. Inamul Hasan Madar | Medicine | Yenepoya Universtiy |India

Dr. Inamul Hasan Madar is a distinguished researcher and educator in the field of biochemistry with a specialization in oncology proteogenomics. He earned his PhD from Korea University, a globally ranked institution, and has since developed extensive expertise in cancer genomics, multiomics integration, and bioinformatics. With a strong commitment to advancing medical research, Dr. Madar has served as an adjunct faculty at Saveetha Medical College (SIMATS), where he has mentored PhD, MD, MBBS, and MSc students in cutting-edge biomedical sciences. His international research experience includes appointments at Korea University and Hanyang University in South Korea, where he contributed to high-impact oncology projects. As Director and Lead of Canary Oncoceutics India, he has bridged the gap between research and industry by leading innovative onco-therapeutic initiatives. Widely published in top-tier journals, Dr. Madar has also served as a reviewer for international journals and as a member of prestigious scientific societies worldwide.

Author profile

Orcid

Education

Dr. Madar’s academic journey reflects a deep pursuit of excellence in biomedical sciences. He earned his PhD in Biochemistry, specializing in Onco-Proteogenomics, from Korea University, Seoul, ranked among the top global universities. His doctoral work focused on proteogenomic profiling and cancer biomarker discovery, positioning him at the forefront of precision oncology. Before this, he pursued advanced training in bioinformatics, molecular biology, and proteomics, equipping him with multidisciplinary skills to tackle complex biomedical challenges. His postgraduate education emphasized molecular diagnostics and computational approaches, while his undergraduate studies laid the foundation in biochemistry and clinical applications. Dr. Madar has also completed specialized training programs in next-generation sequencing (NGS), computational modeling, molecular docking, and drug discovery pipelines. Furthermore, he has been actively engaged in faculty development programs, including pedagogy training for undergraduate teaching in life sciences and biotechnology. This comprehensive educational background underscores his ability to combine research innovation with academic excellence.

Experience

Dr. Madar’s professional experience spans academia, research, and industry. He currently serves as Adjunct Faculty at Saveetha Medical College, SIMATS, where he mentors MBBS, MD, MSc, MPhil, and PhD students in research methodologies, cancer biology, and bioinformatics. He is also Director and Lead (Marketing) at Canary Oncoceutics India, overseeing translational oncology research and innovation in oncoceutical product development. Internationally, he worked as a Visiting Scientist at Korea University, specializing in proteogenomics, and as a Researcher at Hanyang University, Seoul, in bioengineering. In India, his previous roles include Scientist & Course Coordinator at Biocuration, where he designed genomics and drug development modules, and Junior Scientist at iPro Technologies. He has also contributed as a guest lecturer at Bharathidasan University, training future biochemists. His expertise extends to designing computational pipelines, analyzing multiomics datasets, and leading cross-disciplinary projects that bridge laboratory science and clinical application, particularly in cancer therapeutics and biomarker discovery.

Awards and Honors

Dr. Inamul Hasan Madar has received widespread recognition for his contributions to biomedical research and education. His publications in high-impact journals such as Nature Cancer, Oncotarget, Briefings in Bioinformatics, and Molecular Cancer have positioned him among leading voices in proteogenomics and cancer research. He has served as a peer reviewer for several prestigious journals, including Nature’s Scientific Reports, Frontiers in Oncology, BMC Medical Genomics, and Journal of Translational Medicine. He has been actively involved in international professional societies, including the American Association of Cancer Research (AACR), American Society for Biochemistry and Molecular Biology (ASBMB), International Society of Computational Biology (ISCB), and South African and Korean Mass Spectrometry Societies. His leadership roles include serving as Vice President of ISCB-RSG India, demonstrating his dedication to strengthening scientific networks. He has also mentored numerous graduate and medical students, guiding them to publish impactful research, file patents, and develop translational medical applications.

Research Focus

Dr. Madar’s research focus lies at the intersection of cancer genomics, proteogenomics, and computational biology. He specializes in integrating multiomics datasets to identify novel biomarkers and therapeutic targets for treatment-resistant cancers, particularly cervical, prostate, and oral squamous cell carcinoma. His expertise in next-generation sequencing (RNA-Seq, Exome-Seq) and bioinformatics has enabled him to develop innovative pipelines for cancer biomarker discovery, molecular subtyping, and clinical variant interpretation. Beyond oncology, he has contributed to research in neurobiology, metabolic disorders, cardiovascular protection, and bioactive peptides against diabetes and obesity. His translational approach emphasizes the “bench-to-bedside” concept, applying computational models and molecular profiling to guide precision medicine strategies. Dr. Madar has also explored theranostic targets, signaling networks, and novel oncoceutical formulations. His interdisciplinary collaborations with international research groups have advanced drug design, CAR-T therapy applications, and personalized treatment strategies, positioning him as a pioneer in cancer research and translational medicine.

Publications

  • Correction to: Proteogenomic characterization of molecular and cellular targets for treatment-resistant cervical cancers.

  • Molecular analysis of HPV16 and HPV18 oncogenes in oral squamous cell carcinoma.

  • Proteogenomic characterization of treatment-resistant subtypes in cervical cancers.

  • Theranostic Target NSUN2 uncovered with systematic assembly of 805 datasets.

  • Unravelling the phosphoregulatory network of PKC-delta (PKC-δ).

  • BDNF-TrkB signalling: A neurotrophic pathway to cardiovascular protection.

  • Physiological activities of bioactive peptides against diabetes and obesity.

  • SGLT2 inhibitors as dual therapeutic targets for cardiovascular and renal health.

  • Biobased nanomaterials and rhizobacteria for sustainable plant growth.

  • CAR-T therapy in oral squamous cell carcinoma: Current innovations and future prospects.

Conclusion

Dr. Inamul Hasan Madar exemplifies excellence in translational medicine, combining cutting-edge cancer research with dedicated academic mentorship. His impactful publications, international collaborations, and leadership in oncology research position him as a transformative figure in biomedical sciences. Through his expertise in proteogenomics and bioinformatics, he continues to advance precision medicine while inspiring the next generation of medical researchers.

Syed Aasim Syed Nasir | Medicine | Excellence in Research

Mr. Syed Aasim Syed Nasir | Medicine | Excellence in Research

Mr. Syed Aasim Syed Nasir | Medicine | Tbilisi State Medical University | Georgia

Syed Aasim Syed Nasir is a dedicated fourth-year medical student at Tbilisi State Medical University, Georgia, committed to advancing medical research and clinical practice. His academic journey is complemented by extensive research contributions in cardiology, oncology, infectious diseases, and orthopedic surgery. With a growing publication record in reputed journals and conferences, he demonstrates strong skills in investigation, methodology, and medical writing. He has actively presented case reports, systematic reviews, and clinical studies at international platforms, earning recognition for his innovative insights. Beyond research, Syed Aasim is involved in leadership roles within medical organizations, fostering academic collaboration among peers worldwide. His internships and observerships in Dubai and Nigeria further enriched his exposure to diverse healthcare systems. Fluent in multiple languages and active in global medical societies, he exemplifies a well-rounded future physician-researcher with aspirations to bridge clinical medicine, academic excellence, and impactful scientific contributions to global health.

Author Profile

Orcid

Education

Syed Aasim Syed Nasir began his educational journey at Our Own English High School, Sharjah, UAE (2007–2019), where he developed a strong academic foundation. He then pursued his higher education at Velammal Vidhyashram School, Chennai, excelling in the sciences and preparing for a career in medicine. In 2021, he enrolled at Tbilisi State Medical University – School of Medicine, Georgia, where he is currently a Doctor of Medicine candidate. His education extends beyond formal coursework, as he participates in research training, medical writing, and scientific presentations at both national and international levels. His certifications in PALS, First Aid, CPR, ACLS, and BLS (in progress) add clinical preparedness to his academic excellence. Actively engaged in self-directed learning, he complements his curriculum with research in cardiology, oncology, and obstetrics, bridging classroom knowledge with real-world medical applications, shaping him into a future physician-scientist of global relevance.

Experience

Syed Aasim’s experience spans clinical exposure, research collaborations, leadership, and volunteerism. He completed observerships at Zulekha Hospital, Dubai, gaining insights into multidisciplinary patient care, and undertook a Psychnovation Neuroscience Internship, Nigeria, enhancing his research and clinical interpretation skills. He has served as a part-time researcher with the International Journal of Clinical Research (IJCR) and contributed to cardiology projects within IJCR Research Working Group. His leadership roles include General Secretary of ClinNova International, PR Team Member of IJCR Conference, Judiciary Council Member at GIMSOC, and University Head Representative. He also actively participated in Project IMG (USA) as a Unity Agent, furthering international student collaboration. His experiences combine academic rigor with hands-on exposure to clinical medicine, surgical case analysis, systematic reviews, and patient-centered research. These engagements reflect his commitment to developing as a medical leader, researcher, and clinician with both local and international impact.

Awards and Honors

Though early in his career, Syed Aasim has already earned recognition in multiple academic and professional avenues. His posters and case reports have been accepted and presented at high-impact platforms such as the Royal Society of London (2025) and the European Hip Society Congress, Thessaloniki, Greece (2025). His research on oncology, orthopedics, cardiology, and obstetrics has been acknowledged in international medical conferences, highlighting his ability to address complex diagnostic and therapeutic challenges. His selection as Georgia Ambassador for IJCR (2024–2025) underscores his leadership in research dissemination. Additionally, his active participation in medical student societies such as GIMSOC, SSSG, IASSS, and ClinNova International showcases his growing influence in academic medicine. These honors reflect both academic excellence and his proactive approach to advancing collaborative medical research. His consistent recognition in prestigious forums demonstrates his trajectory toward becoming a globally respected physician-researcher in medicine.

Research Focus

Syed Aasim’s research focuses on advancing clinical medicine through a multidisciplinary approach. His work spans oncology, cardiology, orthopedics, neurology, infectious diseases, and obstetrics/gynecology, reflecting his commitment to solving pressing healthcare challenges. He has investigated glioblastoma surgical outcomes, pharmacological mechanisms of UV-induced skin mutations, rheumatological impacts on cardiovascular health, and surgical complexities in gynecological disorders. His systematic reviews and meta-analyses address critical gaps in evidence-based medicine, such as hip arthroplasty, meniscal tear management, and cardiotoxicity biomarkers in cancer patients. He also explores therapeutics in infectious disease management, contributing reviews on measles outbreaks and innovative treatment strategies. His interest in women’s health and perinatal care is reflected in ongoing studies on melatonin supplementation in pregnancy and heart failure outcomes in women versus men. With a balance between clinical case reports, systematic reviews, and mechanistic research, his focus lies in generating translational insights that directly impact patient care and public health.

Publications

  1. A Diagnostic Chameleon: Genital Tuberculosis Mimicking Ovarian Malignancy – Case Report.

  2. Uterine Didelphys with OHVIRA Syndrome: Diagnostic and Surgical Challenges.

  3. Navigating the Pharmacological Landscape of UV-Induced Mutations in Skin Carcinogenesis.

  4. Comprehensive Review of Measles: Outbreak Trends, Clinical Manifestations, and Therapies.

  5. Glioblastoma Surgery: Comparative Study of Resection Degree and Survival Results.

  6. Rheumatoid Arthritis and Cardiovascular Mortality Trends in Postmenopausal Women.

  7. Glioblastoma Multiforme Surgery: Comparative Survival Investigation – IJCR 2024.

  8. Arthroscopic Partial Meniscectomy vs Exercise Therapy for Meniscal Tear: Systematic Review.

  9. Short Stem vs Standard Stem Total Hip Arthroplasty: A Systematic Review.

  10. Melatonin Supplementation in Pregnant Women: Neonatal Brain Maturation Study (In Progress).

  11. Impact of SGLT2 Inhibitors on HFpEF Outcomes: Gender-Based Analysis (In Progress).

  12. Rapid-Onset Obesity with Hypothalamic Dysfunction: Comprehensive Review (In Review).

  13. Infective Endocarditis Post-TAVR vs SAVR: A Comparative Study (In Review).

  14. NT-ProBNP/BNP vs Troponins in Chemotherapy-Induced Cardiotoxicity Detection (In Progress).

  15. Impact of Hydrotherapy in Sports Medicine (In Progress).

Conclusion

Syed Aasim Syed Nasir embodies the qualities of a future physician-scientist: rigorous academic training, international exposure, leadership in medical organizations, and impactful research contributions across diverse medical domains. His growing portfolio of publications, presentations, and leadership roles underscores his ability to bridge clinical practice and academic medicine. With a strong commitment to innovation and patient-centered research, he is positioned to make significant contributions to medicine and global healthcare. His trajectory reflects not only individual excellence but also the potential to influence future medical research and practice on a global scale.

 

Afra Wasama Islam | Medicine | Academic Excellence Award

Ms. Afra Wasama Islam | Medicine | Academic Excellence Award

Ms. Afra Wasama Islam | Medicine | Faculty of Medicine, Tbilisi State Medical University | Georgia

Afra Wasama Islam is a dedicated 5th-year medical student at Tbilisi State Medical University, Georgia, with a strong passion for clinical practice and medical research. She combines technical proficiency in clinical examination, surgical skills, and pharmacotherapy with advanced competencies in wet lab techniques such as ELISA, PCR, and microscopy. As the Chief Executive Officer of ClinNova International, Afra leads a team of over 70 individuals, demonstrating her leadership and management expertise alongside her academic achievements. She actively contributes to global medical communities through her involvement in research clubs, webinars, workshops, and scientific presentations. With publications in international journals and recognition for her work on gastrointestinal health, infectious diseases, and cardiovascular research, she is establishing herself as a promising medical researcher. Her diverse interests, multilingual abilities, and strong creative outlook further complement her vision of advancing healthcare research and practice on a global scale.

Author Profile

Orcid

Education 

Afra Wasama Islam is pursuing her Bachelor of Medicine, Bachelor of Surgery (MBBS) at Tbilisi State Medical University, Georgia, where she is currently in her 5th year of studies (2021–2027). Her academic journey reflects a strong commitment to excellence in both theoretical knowledge and hands-on training. She has acquired comprehensive exposure to medical history-taking, clinical examinations, pharmacotherapy, and advanced surgical procedures. Afra has further strengthened her academic foundation through certifications in Good Clinical Practice (GCP), NIH’s IPPCR course, Basic Surgical Skills, Basic and Pediatric Advanced Life Support, and Healthcare Communication. These achievements demonstrate her dedication to maintaining high standards in medical ethics, patient care, and research methodologies. Her education is also enriched by global exposure, as she participates in international webinars, workshops, and presentations, gaining cross-cultural medical perspectives. With her academic rigor and continuous learning, Afra is well-prepared to contribute significantly to clinical medicine and research innovation.

Experience

Afra’s professional experience highlights her dual strengths in clinical research and leadership. As the CEO of ClinNova International, she manages and mentors a team of 70+, leading global collaborations in medical research. She also serves as a Research Mentor at ClinAcademy and ClinNova International, nurturing future medical researchers. Her leadership extends to positions such as Head of the Creative Department at GCMER Georgia, Co-Head of Workshops at IJCR, and Secretary of the Social Media Chapter at YCC, where she has supervised and trained diverse teams. Afra has actively contributed to academic communities as a Webinar Host for SSSG and a Core Team member of the Research Club at TSMU. Beyond management, she has presented her research at multiple international conferences, covering topics from oncology to robotic surgery. This blend of organizational leadership, clinical knowledge, and academic research positions her as a versatile and impactful emerging medical professional.

Awards and Honors 

Afra Wasama Islam has been recognized for her academic excellence and scientific contributions through various awards and honors. She has presented her research at prestigious platforms such as Eternity (Tbilisi, Georgia), Pulmora, and the Royal Society of Medicine (UK), where her work on topics including lung cancer surgery, spinal cord injury, robotic mastectomy, and stroke prevention has gained significant attention. Her oral and poster presentations reflect her dedication to advancing clinical understanding and innovative practices in medicine. She has also been honored with leadership responsibilities across organizations like ClinNova International, IJCR, and GCMER, highlighting her role as a young leader in medical research. Afra’s certifications from renowned institutions, including the National Institute of Health (NIH) and Clinical Skills Centers, further reinforce her credibility. Her professional memberships with international medical societies showcase her global recognition and commitment to collaborative medical advancement.

Research Focus 

Afra Wasama Islam’s research focus integrates clinical medicine, public health, and translational science. She has explored diverse areas such as neuropsychiatric disorders (Depersonalization-Derealization Disorder), gastrointestinal health (FODMAP diets in IBS patients), and infectious diseases (human metapneumovirus and measles). Her cardiovascular research investigates the implications of L-carnitine and TMAO in heart complications, while her public health studies address zoonotic viral transmission and healthcare strategies. Beyond disease mechanisms, Afra is passionate about digital health, demonstrated in her work on smart inhalers for asthma and COPD, combining medicine with technological innovation. She has also contributed to research on surgical innovations, including robotic versus open mastectomy and thoracotomy versus minimally invasive surgery. This diverse portfolio reflects her forward-looking vision of bridging clinical practice, research, and digital healthcare solutions. With her strong multidisciplinary foundation, Afra aims to contribute to patient-centered healthcare, medical innovation, and global public health improvement.

Publications 

  1. Depersonalization-Derealization Disorder: Etiological Mechanism, Diagnosis and Management.

  2. Comparison of Impact of High vs. Low FODMAP Diet on Gut Flora in IBS Patients.

  3. Clinical Implications of L-Carnitine and Elevated TMAO in Cardiovascular Complications.

  4. Clinical Insights in Human Metapneumovirus Management and Prognosis.

  5. Potential Zoonotic Transmission of HKU5-CoV-2: Host Susceptibility & Public Health Risks.

  6. Comprehensive Review of Measles: Outbreaks, Clinical Manifestations & Therapies.

Conclusion

Afra Wasama Islam exemplifies the qualities of a future leader in medicine combining clinical acumen, innovative research, and effective leadership. With her international publications, research presentations, and executive experience in medical organizations, she has established herself as a promising young professional. Her focus on integrating clinical practice, research, and digital health innovation positions her to make impactful contributions to global healthcare. She is highly suitable for recognition under the Medicine Award, as her work reflects both academic excellence and dedication to advancing human health.

 

Martin Hudec | Medicine | Best Researcher Award

Dr. Martin Hudec | Medicine | Best Researcher Award

Dr. Martin Hudec, Middle-Slovak Institute of Cardiovascular Diseases (SUSCCH), Slovakia

Dr. Martin Hudec is a distinguished Interventional Cardiologist with extensive experience in cardiovascular diseases. He serves as the Head of the Department of Acute Cardiology at the Middle Slovak Institute of Cardiovascular Diseases, Slovakia. Holding multiple prestigious qualifications, including MUDr., PhD., MBA, MRCPI, and FESC, he specializes in percutaneous myocardial revascularization and advanced cardiac interventions. His research focuses on improving treatment outcomes for chronic heart failure patients. Over the years, Dr. Hudec has contributed significantly to Slovak and European cardiology through leadership roles, including as a board member of the Slovak Society of Cardiology. An active researcher and educator, he serves as an External Cardiology Tutor at the Slovak Medical University. Recognized internationally, he is a Fellow of the European Society of Cardiology (FESC) and a Member of the Editorial Board of SEEJCA. His commitment to excellence in interventional cardiology continues to shape the field.

Professional Profile

Scopus

Orcid

Research for Best Researcher Award – Martin Hudec

Dr. Martin Hudec is highly deserving of the Research for Best Researcher Award due to his extensive academic background, notable clinical experience, and impactful contributions to the field of cardiology. As a highly qualified specialist in Interventional Cardiology, Dr. Hudec has demonstrated an exceptional commitment to both patient care and research. His qualifications include a Doctor of Medicine (MUDr.), PhD, MBA, and various prestigious certifications, including the MRCPI (Royal College of Physicians of Ireland) and FESC (Fellow of the European Society of Cardiology). His research has significantly advanced the understanding of myocardial revascularization, especially its impact on chronic heart failure, as demonstrated in his PhD dissertation at Comenius University.

Throughout his career, Dr. Hudec has held influential roles in numerous cardiology societies, including serving as a board member for the Slovak Society of Cardiology and the Slovak Resuscitation Society. His contributions to education and knowledge dissemination are equally remarkable, as he serves as an external cardiology tutor at the Slovak Medical University and is a member of the editorial board for the South East European Journal of Cardiology. These roles underscore his leadership in shaping the next generation of cardiologists and his commitment to advancing the field.

🎓 Education

Dr. Martin Hudec’s medical journey began at the Jessenius Faculty of Medicine, Comenius University, Slovakia, where he graduated with distinction in 2004. He completed his General Professional Training (GPT) in 2006 and earned Membership of the Royal College of Physicians of Ireland (MRCPI) in 2008. Pursuing excellence, he completed his Specialty Certificate in Cardiology (CCT) in 2011 and later defended his PhD dissertation on percutaneous myocardial revascularization and chronic heart failure in 2018. His academic contributions are further recognized through leadership roles, including Board Member of the Slovak Society of Cardiology and Head of the Interventional Cardiology Committee. As an educator, he plays a vital role as a Cardiology Tutor at Slovak Medical University. His academic journey reflects a deep commitment to advancing cardiovascular medicine through education, research, and clinical expertise, shaping the next generation of cardiologists.

💼 Professional Experience 

Dr. Martin Hudec has a stellar career in interventional cardiology, marked by leadership and clinical excellence. Since 2014, he has served as the Head of the Department of Acute Cardiology at the Middle Slovak Institute of Cardiovascular Diseases. He previously held the role of Head of the Coronary Care Unit (2012-2014) and worked as a Consultant Interventional Cardiologist (2011-present). His expertise was further honed during a Fellowship in Interventional Cardiology at Cork University Hospitals, Ireland (2007-2009), before returning to Slovakia as a Specialist Registrar (2009-2011). Dr. Hudec is an External Cardiology Tutor at Slovak Medical University, actively contributing to medical education. His leadership extends to serving on the board of Slovak and European cardiology committees, ensuring the advancement of interventional techniques and patient care. His dedication has positioned him as a key figure in Slovak cardiovascular medicine.

🏅 Awards and Recognition 

Dr. Martin Hudec is a Fellow of the European Society of Cardiology (FESC), a prestigious recognition of his contributions to cardiovascular medicine. He is a Board Member of the Slovak Society of Cardiology and Head of the Interventional Cardiology Committee, reflecting his leadership in the field. His research excellence was acknowledged with a PhD award for his dissertation on myocardial revascularization in 2018. In 2021, he was appointed as a Member of the Editorial Board of the South East European Journal of Cardiology (SEEJCA). Additionally, he played a pivotal role in Slovak Resuscitation Society and ESC eLearning Platform. His consistent efforts in cardiology research and patient care have earned him widespread respect among peers and international recognition. As an advocate for innovation in cardiovascular treatment, Dr. Hudec continues to shape the future of interventional cardiology through education, research, and practice.

🌍 Research Skills On Medicine

Dr. Martin Hudec specializes in interventional cardiology, focusing on percutaneous myocardial revascularization and chronic heart failure treatment. His research integrates advanced cardiovascular imaging, catheter-based interventions, and hemodynamic analysis to improve patient outcomes. He has contributed to evidence-based clinical guidelines, enhancing treatment strategies for acute coronary syndrome and structural heart diseases. His expertise in endovascular techniques and stent technologies has positioned him at the forefront of modern cardiology. As a board member of cardiology committees, he actively participates in international research collaborations. His research extends to resuscitation science, electrophysiology, and cardiovascular risk assessment, aiming to reduce mortality rates in cardiac patients. Dr. Hudec’s work is frequently published in peer-reviewed medical journals, and he plays a crucial role in mentoring young cardiologists. His ability to merge clinical practice with innovative research has made him a leading authority in interventional cardiology.

📖 Publication Top Notes

  • Title: Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosis
    Authors: Niels van Royen, Ignacio J. Amat, Martin Hudec, Patrick W. Serruys, Andreas Baumbach, et al.
    Journal: EuroIntervention
    Year: 2025
    Citations: 2

  • Title: LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial
    Authors: Andreas Baumbach, Niels van Royen, Ignacio J. Amat, Ferencz Arnold-Béla, Orsolya Demeterné Kiss, et al.
    Journal: The Lancet
    Year: 2024
    Citations: 16

  • Title: Evaluation of Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Stents in an All-Comers Patient Population: 1-Year Results of the S-FLEX Slovakia Registry
    Authors: Martin Hudec, Andrej Kupec, Pavol Gazdic, et al.
    Journal: Anatolian Journal of Cardiology
    Year: 2024

 

Apoorva Ramaswamy | Medicine | Best Researcher Award

Assist. Prof. Dr. Apoorva Ramaswamy | Medicine | Best Researcher Award

 👤Assist. Prof. Dr. Apoorva Ramaswamy, The Ohio State University Wexner Medical Center, United States

Dr. Apoorva Tewari Ramaswamy is an Assistant Professor in the Department of Otolaryngology-Head and Neck Surgery at Ohio State University Wexner Medical Center. With a distinguished academic and clinical career, she has contributed significantly to the fields of laryngology and dysphagia. She earned her medical degree from Yale School of Medicine, where she was honored with the prestigious Samuel Jordan Graham Scholarship. Dr. Ramaswamy is dedicated to advancing patient care, research, and education. She has an active role in the Dysphagia Research Society and serves on multiple committees, focusing on diversity, equity, and inclusion (DEI). Her career is marked by academic excellence, innovative research, and an enduring commitment to improving patient outcomes.

Professional Profile

Scopus

Orcid

🌟  Summary of Suitability for the “Research for Best Researcher Award”

Apoorva Tewari Ramaswamy, MD, is exceptionally well-suited for the “Research for Best Researcher Award” due to her extensive educational background, significant research contributions, leadership in her field, and dedication to advancing medical science. She completed her MD from Yale School of Medicine, where she was awarded the Samuel Jordan Graham Scholarship for demonstrating exceptional academic promise in surgery. Additionally, her recognition as Yale College’s Commencement Flag Bearer highlights her extraordinary contributions not only in academia but also within her community.

Dr. Ramaswamy’s research in the fields of laryngology, dysphagia, and esophagology has been widely recognized. She has published influential work, including studies that explore the role of local IgE in eosinophilic esophagitis, which earned her the AAOA Research Prize. Her research contributions continue through her leadership role in various committees and advisory boards, such as the Dysphagia Research Society and the American Broncho-Esophagological Association.

🎓 Education

Dr. Ramaswamy completed her Doctor of Medicine (MD) at Yale School of Medicine (2011–2015), where she was awarded the Samuel Jordan Graham Scholarship for her final year. She also holds a Bachelor of Science in Molecular, Developmental, and Cellular Biology from Yale College (2007-2011), where she was recognized as the Commencement Flag Bearer for her extraordinary contributions. Early in her education, Dr. Ramaswamy earned the “Triple C” award from the Attorney General of New York State, showcasing her excellence in academics and extracurricular leadership during high school. She also demonstrated athletic prowess, earning Volleyball All League honors and the Sirena Wu Dunn Award. Throughout her education, Dr. Ramaswamy’s academic achievements have consistently set her apart as a leader and innovator.

💼 Professional Experience

Dr. Ramaswamy is currently an Assistant Professor at Ohio State University Wexner Medical Center in the Department of Otolaryngology-Head and Neck Surgery. She completed a fellowship in Laryngology and Bronchoesophagology at UC Davis (2020-2021) and residency in Otolaryngology at New York Presbyterian Hospital (2015-2020), where she received several prestigious awards, including the AAOA Research Prize and the Distinguished House Staff Award. Dr. Ramaswamy also has experience working internationally, with a 2009 internship at PEPFAR-Nigeria and research at Yale on vascular surgery. She has served as a faculty member, mentor, and leader in various medical and academic committees, including the Dysphagia Research Society and the American Broncho-Esophagolical Association, advancing research and educational initiatives in her field.

🏅 Awards and Recognition

Dr. Ramaswamy’s career has been marked by several notable accolades. She was honored with the prestigious James Physician Patient Champion Award in 2024. Throughout her residency, she received multiple awards, such as the AAOA Research Prize and In-Service Prize for her academic excellence. As a faculty member, she has received recognition from various professional societies, including the American Head & Neck Society and the Dysphagia Research Society, where she holds leadership positions. Her achievements in academic surgery were further acknowledged with the Distinguished House Staff Award from Weill Cornell Medical Center in 2019, signifying her contributions to patient care, education, and research.

🌍 Research Skills On Medicine

Dr. Ramaswamy’s research is centered around the treatment of dysphagia, laryngology, and the impacts of esophagology on patients with head and neck cancer. Her research contributions have been presented at prestigious international conferences, with a focus on the intersection of voice and swallowing disorders. Dr. Ramaswamy has also conducted studies on local IgE in eosinophilic esophagitis, which won second place at the 2018 AAOA meeting. As a leader in the Dysphagia Research Society and various academic committees, she has promoted diversity and inclusion within the research community. Her work continues to advance understanding of swallowing disorders and provides practical solutions for patient care.

📖 Publication Top Notes

  1. The efficacy of two commercially available devices for airway foreign body relief: A cadaver study

    • Authors: Ramaswamy, A.; Done, A.; Solis, R.; Srikanth, M.; Olinde, L.; Belafsky, P.
    • Citation: Laryngoscope Investigative Otolaryngology, 2023
    • DOI: 10.1002/lio2.1057
  2. Tongue base augmentation to improve swallow function in a cadaveric model

    • Authors: Ramaswamy, A.T.; Cates, D.; Evangelista, L.; Srikanth, M.; Belafsky, P.
    • Citation: Laryngoscope Investigative Otolaryngology, 2023
    • DOI: 10.1002/lio2.1041
  3. The upper esophageal sphincter: anatomy and physiology

    • Authors: Ramaswamy, A.T.; Martell, P.; Azevedo, R.; Belafsky, P.
    • Citation: Annals of Esophagus, 2022
    • DOI: 10.21037/aoe-21-34
  4. Effects of Pyridostigmine on Esophageal and Pharyngeal Motility in Dysphagic Patients Undergoing High-Resolution Manometry.

  5. Office-Based Procedure Training in Laryngology Fellowship Programs.

    • Authors: Enver N.; Ramaswamy A.; Sulica L.; Pitman MJ
    • Citation: The Laryngoscope, 2020-10
    • DOI: 10.1002/lary.29170
    • PMID: 33043999
  6. How I Do It: A Novel Technique for Endoscopic Placement of Stent in Management of Anterior Glottic Webs.

    • Authors: Enver N.; Ramaswamy A.; Pitman MJ
    • Citation: The Laryngoscope, 2020-09
    • DOI: 10.1002/lary.28965
    • PMID: 32902885
  7. Percutaneous and Open Tracheostomy in Patients with COVID-19: Comparison and Outcomes of an Institutional Series in New York City.

    • Authors: Long SM; Chern A; Feit NZ; Chung S; Ramaswamy AT; Li C; Cooley V; Hill S; Rajwani K; Villena-Vargas J, et al.
    • Citation: Annals of Surgery, 2020-09
    • DOI: 10.1097/sla.0000000000004428
    • PMID: 32889885
  8. Common Otologic Surgical Procedures: Clinical Decision-Making Pearls and the Role of Imaging

    • Authors: Peng, T.; Ramaswamy, A.T.; Kim, A.H.
    • Citation: Neuroimaging Clinics of North America, 2019
    • DOI: 10.1016/j.nic.2018.09.008
  9. Management of Vestibular Schwannomas for the Radiologist

  10. Carcinoma presenting as idiopathic anterior glottic webs: A case series

    • Authors: Ramaswamy, A.T.; Tian, L.; Bock, J.M.; Klein, A.M.; Pitman, M.J.
    • Citation: The Laryngoscope, 2019-09
    • DOI: 10.1002/lary.27711

Sarah Depallens | Medicine | Best Researcher Award

Dr. Sarah Depallens | Medicine | Best Researcher Award

👤 Dr. Sarah Depallens, CAN team Lausanne CHUV, Switzerland

Dr. Sarah Depallens, an accomplished pediatrician born on February 15, 1977, in Lausanne, Switzerland, has made a profound impact in child healthcare. Serving as an Associate Physician at CHUV, she leads the CAN Team (since 2017), the General Pediatrics Outpatient Clinic (since 2023), and the Migratory Pediatrics Consultation (since 2024). Her career spans two decades, marked by expertise in pediatrics, child abuse prevention, and healthcare for vulnerable populations. Dr. Depallens earned her medical degree from the University of Lausanne in 2002 and became a FMH Specialist in Pediatrics in 2011. Her dedication to improving pediatric care is evident in her extensive professional experience, numerous publications, and advocacy for child welfare. Fluent in multiple languages and globally oriented, she is known for her compassionate approach and leadership in addressing healthcare challenges for children and adolescents.

Professional Profile

Orcid

🌟  Suitability for the Research for Best Researcher Award: Dr. Sarah Depallens

Dr. Sarah Depallens exemplifies the qualities of an outstanding researcher and academic leader, making her a highly suitable candidate for the Research for Best Researcher Award. Her extensive professional experience in pediatrics, public health, and migration health reflects a deep commitment to advancing the field and addressing complex societal challenges. As a Médecin Associé and leader of multiple pediatric initiatives at the CHUV (Centre Hospitalier Universitaire Vaudois), Dr. Depallens demonstrates exceptional leadership, innovation, and dedication to improving healthcare for vulnerable populations.

Research Contributions and Professional Impact : Dr. Depallens has significantly contributed to academic research, with an impressive array of publications in high-impact journals addressing critical topics such as child abuse detection, pediatric refugee healthcare, and the psychological impacts of migration on children. Her work combines clinical expertise with public health strategies, as seen in her studies on abusive head trauma, migrant health, and pediatric violence exposure.

🎓 Education 

Dr. Sarah Depallens’ academic journey reflects a commitment to excellence in medicine. She earned her medical degree in 2002 from the University of Lausanne, followed by a doctorate in 2010 with her thesis on healthcare for undocumented children. Dr. Depallens holds the FMH Pediatric Specialist title (2011), reinforcing her expertise in pediatrics. Further enriching her professional profile, she obtained certifications in Public Health (2012) from KMC, India, and medico-legal care for violence survivors (2013). Recognizing the importance of leadership, she completed a CAS in Management for Executives (2017) and a MicroMBA (2024) at CHUV. Her diverse educational experiences include international rotations in Mexico, Cuba, and Switzerland, offering a well-rounded perspective on healthcare challenges. This robust educational foundation underpins her innovative work in pediatric care, advocacy, and research.

💼  Professional Experience 

Dr. Sarah Depallens’ professional journey spans over 20 years, reflecting her expertise in pediatrics and leadership. She began as a Medical Assistant in General Pediatrics (2003-2004) and expanded her experience through roles in Pediatric Surgery, Emergency Medicine, and Neonatology at CHUV and HEL in Lausanne. From 2008 to 2016, she held pivotal roles in multidisciplinary pediatric units, specializing in adolescent health and child abuse prevention. Her international experience includes a year in General Pediatrics at KMC Hospital, India (2011-2012). Since 2017, Dr. Depallens has led the CAN Team at CHUV, addressing child abuse with innovative strategies. She also heads the General Pediatrics Outpatient Clinic and Migratory Pediatrics Consultation, emphasizing healthcare for marginalized children. Her holistic approach and leadership have established her as a pioneer in pediatric medicine.

🏅 Awards and Recognitions

Dr. Sarah Depallens has received several accolades for her contributions to pediatrics. Her pioneering work in child abuse prevention and healthcare for vulnerable populations has earned her recognition both nationally and internationally. She received CHUV’s Excellence in Leadership Award (2020) for her innovative strategies in multidisciplinary pediatric care. Her thesis on undocumented children’s health was awarded the Best Research Thesis by the University of Lausanne (2010). Additionally, her efforts in medico-legal pediatric care earned her the Swiss Pediatric Society Recognition Award (2018). Dr. Depallens has also been lauded for her global outreach, receiving a Certificate of Public Health distinction from KMC, India (2012). Through her publications and advocacy, she continues to inspire advancements in child healthcare, cementing her reputation as a leader in pediatrics.

🌍 Research Skills On Medicine 

Dr. Sarah Depallens’ research skills center on pediatrics, public health, and child abuse prevention. She excels in designing multidisciplinary studies, evidenced by her work on abusive head trauma and the health needs of migrant children. Proficient in quantitative and qualitative methodologies, she collaborates with experts in pediatrics, psychology, and law to develop comprehensive insights into child welfare. Dr. Depallens’ ability to analyze complex data has led to over 20 peer-reviewed publications, addressing topics like pediatric refugees, adolescent health, and medico-legal evaluations. Her research often translates into actionable policies, underscoring her skill in bridging science and practice. Adept in academic writing and presentation, she shares findings at international conferences, fostering global collaboration.

📖 Publication Top Notes

  • Maternal risk factors for infant foster care from birth: a retrospective observational study
    • Authors: Inés Blanco Lara, Antje Horsch, Roger Hilfiker, Sarah Depallens, Vania Sandoz
    • Year: 2025
  • Enfants et adolescent-e-s dans un environnement négligent. La détection précoce comme première réponse à leurs besoins
    • Authors: Cyril Knob, Vania Sandoz, Sarah Depallens
    • Year: 2024
  • Pédiatrie. Consultation en pédiatrie pour les enfants victimes de violence conjugale
    • Authors: Janique Sangsue, Vania Sandoz, Edelweiss Kabwiku, Sarah Depallens
    • Year: 2024
  • Prosecuting cases of abusive head trauma in Switzerland: a descriptive study of the impact of medical documentation and delay of reporting on judicial outcome
    • Authors: Sarah Held, Jean-Jacques Cheseaux, Jean-François Tolsa, Sarah Depallens
    • Year: 2024
  • SECURE: un outil pour évaluer les mineurs victimes de violences conjugales
    • Authors: Janique Sangsue, Sarah Depallens
    • Year: 2023
  • [Assessment of families in situations of forced migration: Transcultural approaches to identifying and supporting psychological suffering].
    • Authors: Javier Sanchis Zozaya, Sydney GAULTIER, Sarah Depallens
    • Year: 2023
  • Paediatric refugees from Ukraine: guidance for health care providers.
    • Authors: Jaeger FN, Christoph Berger, Michael Buettcher, Sarah Depallens, Heininger U, Heller Y, Kohns Vasconcelos M, Leforestier B, Pellaud N, Relly C et al.
    • Year: 2022
  • [Mobbing amongst students: from detection to care: How to work together?]
    • Authors: Redzepi V, Sangsue J, Lugon J, Sarah Depallens
    • Year: 2022
  • Early Diagnosis of Abusive Head Trauma to Avoid Repetitive Shaking Events
    • Authors: Sarah Depallens, Celine Favrod, Philippe Maeder, Diego San Millan, Jean-Jacques Cheseaux
    • Year: 2022
  • Jugendliche mit Migrationshintergrund – Herausforderung für die allgemeine Gesundheit, über welche Hilfsmittel verfügen Kinderärztinnen und Kinderärzte?
    • Authors: Sarah Depallens, Caroline Heiniger, Karine Tzaud
    • Year: 2021

Alfredo Gongora | Health Professions | Best Researcher Award

Dr. Alfredo Gongora | Health Professions | Best Researcher Award

👤 Dr. Alfredo Gongora, Centro de Fertilidad Humana en México, Mexico

Dr. José Modesto Alfredo Góngora Rodríguez is a distinguished expert in reproductive medicine and gynecology. As Chairman of the Board and General Director at Centro de Fertilidad Humana, Mexico, he has pioneered key advancements in germ cell cryopreservation, sperm DNA fragmentation studies, and oxidative stress research in sperm. His contributions have significantly shaped the field of reproductive health in Mexico. Dr. Góngora holds a medical degree from the National Autonomous University of Mexico (UNAM) and a specialization in gynecology and obstetrics from Complutense University in Madrid, Spain. With numerous recertifications, he remains a leader in clinical excellence and innovation. Dr. Góngora is also an honorary member of various national and international medical societies, reflecting his global influence in the field. His commitment to advancing human reproductive health continues to inspire both practitioners and researchers worldwide.

professional Profile

Scopus

Orcid

🌟 Assessment of Suitability for the Research for Best Researcher Award: Dr. José Modesto Alfredo Góngora Rodríguez

Dr. José Modesto Alfredo Góngora Rodríguez is a distinguished expert in human reproductive medicine, with a remarkable career spanning several decades. His pioneering contributions to germ cell cryopreservation, sperm DNA fragmentation studies, and oxidative stress research in sperm have made significant impacts in the field of reproductive biology. These groundbreaking achievements demonstrate his innovative approach and dedication to advancing medical science, making him a strong candidate for the Research for Best Researcher Award.

Dr. Góngora Rodríguez’s extensive educational background and specialization in gynecology, obstetrics, and human reproductive biology underscore his academic rigor and professional commitment. He has been certified and recertified multiple times by the Mexican Board of Gynecology and Obstetrics, reflecting his continuous pursuit of excellence and adherence to the highest standards in his field.

🎓  Education

Dr. Góngora’s academic journey began with a medical degree from the National Autonomous University of Mexico (UNAM) and La Salle University, where he studied from 1973 to 1978. He further specialized in gynecology and obstetrics, completing his postgraduate studies at Complutense University, Hospital Clínico de San Carlos in Madrid, Spain, under the mentorship of Prof. José Botella Llusia. Additional training took place at Hospital de México, solidifying his expertise. His credentials include professional licenses and specialty certifications from the Mexican Board of Gynecology and Obstetrics, with multiple recertifications spanning over two decades. Dr. Góngora has also specialized in human reproductive biology, ensuring his practice aligns with the latest advancements in the field. His dedication to continuous learning and professional development underscores his esteemed reputation as a leader in gynecology and reproductive medicine.

💼 Professional Experience

Dr. José Modesto Alfredo Góngora Rodríguez’s illustrious career is marked by leadership roles and groundbreaking contributions to reproductive medicine. As Chairman of the Board and General Director at Centro de Fertilidad Humana in Mexico, he has pioneered advancements in germ cell cryopreservation, sperm DNA fragmentation, and oxidative stress studies in sperm. His clinical expertise spans decades, complemented by his active participation in numerous national and international medical societies. Dr. Góngora’s professional milestones include founding memberships in esteemed organizations such as the Mexican College of Gynecological Endoscopy and Hysteroscopy. His collaborations with international societies, such as the European Society of Human Reproduction and Embryology, further showcase his global influence. Renowned for his innovative approaches, Dr. Góngora has successfully integrated cutting-edge research into clinical practice, enhancing patient outcomes and advancing the field of human reproduction.

🏅 Awards and Recognitions 

Dr. Góngora’s achievements have earned him prestigious awards and recognitions in reproductive medicine. He is an honorary member of the Mexican College of Specialists in Gynecology and Obstetrics, reflecting his national contributions. He has also been honored by the Mexican Association of Reproductive Medicine and various international societies, including the British Fertility Society and the International Society for Fertility Preservation. His founding memberships in organizations such as the Mexican College of Gynecological Endoscopy and the Medical Society of Ángeles de las Lomas highlight his pioneering spirit. Through multiple recertifications from the Mexican Board of Gynecology and Obstetrics, Dr. Góngora has maintained clinical excellence. These accolades, coupled with his active participation in global medical societies, underscore his lasting impact on advancing reproductive health and gynecology, both in Mexico and internationally.

🌍 Research Skills On Health Professions

Dr. Góngora possesses exceptional research skills, focusing on human reproductive health. His groundbreaking work in germ cell cryopreservation has set benchmarks in fertility preservation techniques. He has conducted pioneering studies on sperm DNA fragmentation, offering valuable insights into male infertility diagnostics and treatment. His research on oxidative stress in sperm has advanced understanding of reproductive biology, influencing clinical protocols globally. Dr. Góngora’s dedication to evidence-based practices is evident in his collaboration with international medical societies, where he integrates cutting-edge findings into clinical applications. His ability to merge research with practice ensures high-quality patient care and contributes to the broader field of reproductive medicine.

📖 Publication Top Notes

1. Sperm Human Biobanking: An Overview
  • Authors: Góngora, A.; Holt, W.V.; Gosálvez, J.
  • Year: 2024
  • Journal: Archives of Medical Research
2. Strong Correlation Between Double-Strand DNA Breaks and Total Sperm DNA Fragmentation in the Human Ejaculate
  • Authors: Gosálvez, J.; Johnston, S.D.; Prado, A.; de la Vega, C.G.; Góngora, A.
  • Year: 2024
  • Journal: Archives of Medical Research
3. Multi-Centre Assessment of Nitroblue Tetrazolium Reactivity in Human Semen as a Potential Marker of Oxidative Stress
  • Authors: Gosálvez, J.; Coppola, L.; Fernández, J.L.; Johnston, S.; Esteves, S.C.
  • Year: 2017
  • Journal: Reproductive BioMedicine Online